The Brazilian company is a global leader in animal protein-based products and entered the health and nutraceuticals market with the launch of Genu-in. Investments in the new plant totaled BRL 400 million (about USD 78,1 million).
LATEST NEWS
- Pharmaceutical plant opens in Oman
- Palmeiras U-19 to play in Morocco
- UAE horse championship to hold final in Brazil
- Brazil negotiates urea purchase from Indonesia
- Brazilian theater company and Morocco link
- Real estate mission to Dubai postponed to October
- Algeria opens bidding round for oil exploration
- Qatar to gradually resume foreign airline flights
